Somerville, MA, United States of America

Mark Smith

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Finch Therapeutics Holdings LLC, Millennium Pharmaceuticals Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Smith. Retrieved from https://idiyas.com/inventor/mark-smith-o690xa77

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Mark Smith in Gastrointestinal Treatment

Introduction

Mark Smith is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of gastrointestinal health through his innovative approaches and research. With a focus on microbial therapeutics, his work aims to address disorders related to intestinal dysbiosis.

Latest Patents

Mark Smith holds 1 patent for his invention titled "Methods and products for treatment of gastrointestinal disorders." This patent describes compositions and methods for the delivery of microbial therapeutics that are useful for treating various gastrointestinal disorders.

Career Highlights

Throughout his career, Mark has worked with notable companies in the biotechnology sector. He has been associated with Finch Therapeutics Holdings LLC and Millennium Pharmaceuticals Limited, where he has contributed to advancing therapeutic solutions.

Collaborations

Mark has collaborated with talented individuals in his field, including Anh-Thu Elaine Vo and Rotem Sadovsky. Their combined expertise has furthered the development of innovative treatments in gastrointestinal health.

Conclusion

Mark Smith's work in the field of gastrointestinal disorders showcases his dedication to improving health outcomes through innovation. His contributions are paving the way for new therapeutic approaches that can benefit many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…